Literature DB >> 19632190

Progressive degradation of serum samples limits proteomic biomarker discovery.

Shadab Ahmad1, Elayanambi Sundaramoorthy, Reena Arora, Somdutta Sen, Ganesan Karthikeyan, Shantanu Sengupta.   

Abstract

Preanalytical variables play a key role in discovery of biomarkers. Although the effect of several preanalytical variables on the mass spectral profiles has been studied extensively, little is known about long-term storage of serum samples. This is important because samples used in case-control or epidemiological studies are usually stored for a long time before analysis. Here we evaluated long-term storage effects on mass spectral peak patterns of serum peptides extracted using weak cation exchange magnetic beads. For this, 20 serum samples stored at -80 degrees C were divided equally into two groups based on their storage time. We found that intensities of 26 mass spectral peaks significantly varied between these two groups. Intensities of these peaks significantly correlated with storage time. Genetic algorithm-based models generated using these 26 peaks could classify 63 additional samples into these two groups with 100% and 96% accuracy, respectively. We also show that storing samples for 10 months at -80 and -20 degrees C results in the appearance/disappearance or intensity variation of peaks, some of which were previously reported as disease biomarkers.

Mesh:

Substances:

Year:  2009        PMID: 19632190     DOI: 10.1016/j.ab.2009.07.029

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  Biobanking and international interoperability: samples.

Authors:  Michael Kiehntopf; Michael Krawczak
Journal:  Hum Genet       Date:  2011-07-15       Impact factor: 4.132

2.  -Omics and cancer biomarkers: link to the biological truth or bear the consequences.

Authors:  Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-07-18       Impact factor: 4.254

3.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

Review 4.  Toxicogenomic profiling of chemically exposed humans in risk assessment.

Authors:  Cliona M McHale; Luoping Zhang; Alan E Hubbard; Martyn T Smith
Journal:  Mutat Res       Date:  2010-04-09       Impact factor: 2.433

5.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

6.  Plasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathway.

Authors:  Trayambak Basak; Vinay Singh Tanwar; Gourav Bhardwaj; Nitin Bhardwaj; Shadab Ahmad; Gaurav Garg; Sreenivas V; Ganesan Karthikeyan; Sandeep Seth; Shantanu Sengupta
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

7.  Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure.

Authors:  Kai Liang; Hongmei Wu; Tony Y Hu; Yan Li
Journal:  Clin Proteomics       Date:  2016-11-22       Impact factor: 3.988

8.  Serum is not required for ex vivo IFN-gamma ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program.

Authors:  A Mander; C Gouttefangeas; C Ottensmeier; M J P Welters; L Low; S H van der Burg; C M Britten
Journal:  Cancer Immunol Immunother       Date:  2010-01-06       Impact factor: 6.968

9.  Individual variations in serum melatonin levels through time: implications for epidemiologic studies.

Authors:  Leticia M Nogueira; Joshua N Sampson; Lisa W Chu; Kai Yu; Gerald Andriole; Timothy Church; Frank Z Stanczyk; Jill Koshiol; Ann W Hsing
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

10.  Towards Harmonized Biobanking for Biomonitoring: A Comparison of Human Biomonitoring-Related and Clinical Biorepositories.

Authors:  Dominik Lermen; Frederik Gwinner; Martina Bartel-Steinbach; Sabine C Mueller; Jens K Habermann; Matharoo-Ball Balwir; Elke Smits; Ana Virgolino; Ulrike Fiddicke; Marika Berglund; Agneta Åkesson; Anna Bergstrom; Karin Leander; Milena Horvat; Janja Snoj Tratnik; Manuel Posada de la Paz; Argelia Castaño Calvo; Marta Esteban López; Hagen von Briesen; Heiko Zimmermann; Marike Kolossa-Gehring
Journal:  Biopreserv Biobank       Date:  2020-04       Impact factor: 2.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.